Atlas Trials

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Clinical trial NCT00232726 · COMPLETED

Trial details

NCT number
NCT00232726
Sponsor
Clavis Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant MelanomaNeoplasm Metastasis
Start date
2005-09-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.